Kazakhstan Simplifies Pharmaceutical Registration: New Opportunities for International Manufacturers

Kazakhstan continues to improve the regulation of its pharmaceutical market by shortening the registration periods for medicinal products and reviewing pricing mechanisms. These changes are aimed at expanding the range of medicines, promoting competition and improving public access to quality medicines.
The ongoing reforms were outlined by Minister of Healthcare of the Republic of Kazakhstan
Aqmaral Älnazarova, commenting on issues related to the cost of medicinal products and their availability on the domestic market.
Registration of Medicinal Products: From Several Years to Several Months
One of the key areas of the reforms has been the simplification of medicinal product registration procedures. According to the Minister, registration previously could take between two and five years. As a result of the legislative amendments introduced, significantly shorter timeframes have been established:
- 15 working days — for medicinal products from countries with highly developed regulatory systems;
- Up to 100 working days — in all other cases.
The optimisation of registration procedures is intended to facilitate the entry of foreign medicinal products into the Kazakhstan market, contribute to expanding the range of medicines and strengthen competition among manufacturers.
Review of Pricing Mechanisms and Development of Competition
At the same time, the Ministry of Healthcare of the Republic of Kazakhstan is working to improve pricing policies in the pharmaceutical industry. Over the past three years, approaches to pricing in the wholesale and retail segments, as well as within the single distributor system, have been revised. According to the figures announced, the savings achieved by the single distributor increased from KZT 23 billion at the end of 2023 to more than KZT 125 billion over 2024–2025.
Particular attention is being paid to creating favourable conditions for high-quality foreign-manufactured medicinal products to enter the market, including products from Türkiye.
The increased presence of international manufacturers is expected to promote competition, expand the range of medicines and improve their availability in Kazakhstan.
PharmaTECH Kazakhstan 2027: Opportunities to Enter the Pharmaceutical Market of Kazakhstan
Against the background of changes in the regulation of Kazakhstan's pharmaceutical market, international industry cooperation is becoming particularly relevant.
The 4th Kazakhstan International Exhibition PharmaTECH Kazakhstan 2027 will take place on 19–21 May 2027 in Almaty, at the Atakent IEC.
The exhibition will bring together manufacturers of finished pharmaceutical products, pharmaceutical companies, suppliers and other industry representatives interested in developing business relations in the markets of Kazakhstan and Central Asia.
As part of the PharmaTECH Kazakhstan 2027 Hosted Buyers Programme, delegations from the Ministry of Healthcare of the Republic of Kazakhstan and SK-Pharmacy LLP are planned to be invited to learn about new manufacturers and potential suppliers of medicinal products, as well as to participate in B2B meetings.
Participation in the exhibition will provide companies with an opportunity to present their product ranges, establish direct contacts with representatives of Kazakhstan's pharmaceutical market and discuss prospects for further cooperation.
We invite international and Kazakhstani manufacturers of medicinal products to participate in PharmaTECH Kazakhstan 2027.
Book a stand: https://pharmatechexpo.kz/en/book-a-stand
Source: Adal Adam. Comments by Minister of Healthcare of the Republic of Kazakhstan
Aqmaral Älnazarova.
Exhibition Organisers: Iteca, ICA Events.
- Created on .



